rxstatShortages › Alendronic Acid Vitamin D3

Alendronic Acid Vitamin D3 shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Alendronic Acid Vitamin D3 products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 of 8
In shortage since
Oct 30, 2017
Reports on file
35
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-ALENDRONATE/CHOLECALCIFEROL
70MG 2800UNIT · TABLET · TEVA CANADA LIMITED
DIN 02403633 · since Oct 30, 2017, no end estimate · Shortage of an active ingredient.
Active shortage
TEVA-ALENDRONATE/CHOLECALCIFEROL
70MG 5600UNIT · TABLET · TEVA CANADA LIMITED
DIN 02403641 · since Nov 20, 2017, no end estimate · Shortage of an active ingredient.
Resolved
JAMP ALENDRONATE / VITAMIN D3
70MG 2800UNIT · TABLET · JAMP PHARMA CORPORATION
DIN 02519828 · ended Mar 4, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ALENDRONATE/VITAMIN D3
2800UNIT 70MG · TABLET · APOTEX INC
DIN 02454467 · ended Feb 26, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ALENDRONATE/VITAMIN D3
5600UNIT 70MG · TABLET · APOTEX INC
DIN 02454475 · ended Feb 26, 2026 · Disruption of the manufacture of the drug.
Resolved
FOSAVANCE
2800UNIT 70MG · TABLET · ORGANON CANADA INC.
DIN 02276429 · ended Oct 30, 2025 · Delay in shipping of the drug.
Resolved
FOSAVANCE
5600UNIT 70MG · TABLET · ORGANON CANADA INC.
DIN 02314940 · ended Sep 12, 2025 · Delay in shipping of the drug.
Resolved
FOSAVANCE
2800UNIT 70MG · TABLET · ORGANON CANADA INC.
DIN 02276429 · ended Aug 16, 2024 · Delay in shipping of the drug.
Resolved
FOSAVANCE
5600UNIT 70MG · TABLET · ORGANON CANADA INC.
DIN 02314940 · ended Sep 13, 2023 · Demand increase for the drug.
Resolved
FOSAVANCE
5600UNIT 70MG · TABLET · ORGANON CANADA INC.
DIN 02314940 · ended Jun 20, 2023 · Demand increase for the drug.
Resolved
APO-ALENDRONATE/VITAMIN D3
5600UNIT 70MG · TABLET · APOTEX INC
DIN 02454475 · ended Jun 15, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ALENDRONATE/VITAMIN D3
2800UNIT 70MG · TABLET · APOTEX INC
DIN 02454467 · ended Apr 20, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 35 reports. All reports are on file with Health Canada.

What's happening

Alendronic Acid Vitamin D3 is currently affected by 2 active shortage reports filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Alendronic Acid Vitamin D3 is classified under “DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION” (ATC M05BB).

Recent changes

Common questions

When will Alendronic Acid Vitamin D3 be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Alendronic Acid Vitamin D3 in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs affecting bone structure and mineralization)

All drugs affecting bone structure and mineralization shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.